Introduction
The present study was conducted as an exploratory probe to test the hypothesis that thin malignant melanoma lesions comprise two phenotypes of nuclei and that lesions which have the potential to progress to metastatic disease contain a higher proportion of one of these two phenotypes of nuclei. The hypothesis was prompted by results obtained from recent studies of clinical materials from atypical hyperplasia of the endometrium [1] and from cutaneous squamous cell cancer (cSCC) [2, 3] .
For both lesions of atypical endometrial hyperplasia and cSCC, there are two axes of dispersion for karyometric variables. One axis involves variables known to undergo a monotonic increase in value with progression to malignant disease, such as total optical density and relative nuclear area. The other independent axis of dispersion separates cases with the potential to progressive development from cases that remain indolent. The distinguishing karyometric features here reflect the spatial and statistical distribution of the nuclear chromatin. Changes in the chromatin distribution pattern are not necessarily visually perceived, but have been established and statistically secured by image analytic procedures. In the study of cSCC lesions, up to 85% of cases with poor prognosis could be recognized on that basis. For both of the above-mentioned lesions, the following quantities were established: the presence of two phenotypes of nuclei, and the association of a high proportion of nuclei of one of these phenotypes with invasive disease or aggressive disease development.
Melanomas that are 0.75-1 mm thick have ∼ 5% risk of metastasis; those less than 0.75 mm thick metastasize even less frequently [4] [5] [6] . Patients with melanomas thicker than 1 mm have a higher risk of metastasis, and they often undergo sentinel lymph node biopsy because of the thickness of their melanomas. Currently the most powerful prognostic features in patients with thin cutaneous melanomas (< 1 mm thick) are tumor depth/thickness, ulceration [4] , and mitosis [5] . Usually, the initial site of metastasis is the regional lymph node basis [7] .
Given the low probability of metastasis in patients with thin melanomas, identification of those melanomas that are at highest risk represents an opportunity for more personalized surgical treatment. However, as Bjoernhagen et al. [8] have emphatically pointed out, even thin melanomas may metastasize and the above criteria may not unequivocally predict clinical outcome.
There is a sizable literature dedicated to relating specific prognostic characteristics to thin melanomas. Tan and Baak [9] investigated the utility of karyomorphometric characteristics such as nuclear shape for prognosis [10] . Li et al. [11] though, in 2004, discounted the general efficacy of morphometric criteria, such as nuclear shape factors, in the context of their own comprehensive evaluation of potentially useful prognostic clues. A number of studies in malignant melanoma lesions have involved DNA measurements to obtain prognostic indicators [8] [9] [10] [11] .
The present study is based on a multivariate discriminant analysis of the spatial and statistical distribution of the nuclear chromatin. These procedures have been found to provide an exquisite sensitivity for the detection of small differences between two nuclear phenotypes.
Materials and methods

Patients and clinical materials
The study was approved by the University of Arizona institutional review board. Twenty-eight patients with thin melanomas who underwent resection from January 2006 to December 2008 and who had no evidence of metastasis at diagnosis were retrospectively identified. The index procedures occurred at two institutions, the Arizona Cancer Center (n = 22) and Hospital Sao Paulo, Pontifícia Universidade Católica do Rio Grande do Sul (n = 6). Clinicopathologic and follow-up data were reviewed for ulceration and mitotic index.
Patient characteristics
All 28 patients underwent wide local resection with at least 1 cm margins. Of the 18 patients in the nonmetastatic group, four had undergone sentinel or auxiliary lymph node biopsy at the discretion of the surgeon at the time of initial excision, as compared with seven of the 10 patients in the metastatic group. By definition none of the patients in the nonmetastatic group were found to have positive lymph nodes during their index procedure, as compared with three patients in the metastatic group. We do not precisely know how surgeons decided how to proceed with sentinel node biopsy but factors such as elevated mitotic rate or melanoma thickness close to 1.0 mm may have caused surgeons to perform sentinel lymph node biopsy.
Clinical outcomes
At the time of follow-up all patients in the metastatic group had developed both lymph node and distant metastases, as compared with none in the nonmetastatic group. The sites of distant metastases included the small intestines, lungs, bones, chest wall, extremities and abdominal wall.
Tumor characteristics
The thickness of the primary index tumor in the nonmetastatic group was 0.53 0.25 mm; in the metastatic group it was 0.68 0.26 mm (P = 0.20). Tumors arose in similar anatomic locations in both groups. None of the melanomas in either group had ulceration. None of the melanomas in the nonmetastatic group had a high mitotic index; there was one such case in the metastatic group.
Clinical materials
The pathologic specimens were fixed in 10% neutral buffered formaldehyde. Paraffin-embedded tumor blocks were obtained from the pathologic archives of the two institutions. Sections (5 μm) were cut for each sample. Staining with hematoxylin and eosin was done under routine clinical standard operating procedures. A pathologist or dermatopathologist confirmed each section to be a representative sample of the melanoma lesion.
Data recording
Data were recorded on a videomicrophotometer equipped with a 100 : 1 numerical aperture, 1.40 plan apochromatic oil immersion objective (Nikon Metrology, Brighton, Missouri, USA). Relay optics adjusted the magnification for a sampling density of 6 pixels per linear micron. A 610 nm bandpass interference filter was used to enhance contrast.
For the 10 cases where stage III or IV metastatic progression had occurred, 1148 nuclei were recorded. For the 18 cases with no metastatic progression, 2084 nuclei were recorded. Two data sets were established, for nuclei from cases with no metastatic progression (M), and for nuclei from cases with metastatic progression (Mmeta).
A set of 93 karyometric features was computed. Feature selection for a discriminant analysis was based on a Kruskal-Wallis test [12] , and the ambiguity function of Genchi and colleagues [13, 14] .
A Bonferroni correction, a value of P less than 0.0001 was used as threshold. To derive a classification rule for lesions expected to progress to metastasis versus those expected not to do so, a discriminant function was used. This function was then applied to each case, and the proportion of nuclei assigned to the Mmeta category was determined.
It was hypothesized that lesions of both diagnostic categories each contain the same nuclei of two different phenotypes, but in different proportions. Since nuclei of the two phenotypes cannot be visually identified, training of the discriminant function has to be done on the characteristics of nuclei from lesions with, or with no metastatic progression. The computed karyometric mean values of nuclei thus depend on the relative proportions of the two phenotypes in each case. There is a small difference between the karyometric values of nuclei of pure phenotype and the values used in the discriminant algorithm. It is important therefore to distinguish between a 'nucleus from a case of metastatic progression' and a 'nucleus of the phenotype predominant in cases of metastasis', because the nuclei from a case of metastatic progression would contain both aggressive and nonaggressive phenotypes.
Results
The study group included 18 patients with nonmetastatic disease (13/18 male) and 10 patients (6/10 male) with metastatic disease. The overall median follow-up time was 4.6 years. The average age in the nonmetastatic group was 62 15 years; in the metastatic group it was 50 16 years. In both groups, most patients were male. Of the 18 patients with nonmetastatic disease, 10 lesions were in the thoracoabdominal region, four were located on the extremities, and four were located on the face/ head/scalp/ears. Of the 10 patients with metastatic disease, four were located in the thoracoabdominal region, two were located on the extremities, and four were located on the face/head/scalp/ears. The majority of melanomas in both groups were in the vertical growth phase while similar minorities in both groups were identified as superficial spreading melanoma.
The notable dispersion of mean values for karyometric variables is shown (Fig. 1) , for both diagnostic categories, as a bivariate plot of the key variables: total optical density and relative nuclear area. The total optical density, reflecting ploidy, varied by a factor of 2, and relative nuclear area by a factor of 2-3. The plot shows that the distribution of cases with potential progression and for cases that remain indolent cover the same range, and the plot also shows that progression to metastatic disease occurs independently of total optical density, that is, even in cases with near diploid DNA content.
The feature selection for a discriminant analysis identified more than 20 karyometric features with statistically significant differences at P value less than 0.0001. Most of these features represent texture differences of the nuclear chromatin. In the following, all feature values are given in arbitrary, relative units.
Training and test sets
A training set of five cases of the metastatic lesions (M) with 591 nuclei, and of nine cases of the nonmetastatic lesions (Mmeta), with 1085 nuclei was formed. Table 1 lists five selected features with their mean values and standardized coefficients in the discriminant function. The classification matrix for nuclei is shown in Table 2 . The average accuracy was 64.3%.
The algorithm assigned a negative sign to nuclei from the metastatic cases. The score distributions are shown for the training sets of five and nine cases in Fig. 2 . The 
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A bivariate plot of total optical density and relative nuclear area. This plot shows that the distribution of cases with potential progression and for cases that remain indolent cover the same range, and the plot also shows that progression to metastatic disease occurs independently of total optical density, that is, even in cases with near diploid DNA content. 
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decision rule was next applied to the test set of five cases from the metastatic lesions, with 557 nuclei, and to the remaining nuclei from the nine cases of nonmetastatic lesions, with 896 nuclei.
Using as a case classification criterion the percentage of nuclei assigned to the metastatic lesion category, and a 50% threshold, the classification resulted, for the training set, in the correct assignment of 4/5, or 80% of the metastatic lesions, and 6/9, or 67% of the nonmetastatic lesions, for an average accuracy of 10/14, or 71%.
For the test set, the discriminant function assigned 3/5, or 60% of the metastatic cases correctly, and 8/9 or 89% of the nonmetastatic cases, for an average accuracy of 11/14, or 79%.
If a 40% assignment of nuclei to the Mmeta category is used as a case classification criterion, the training set data results in an average accuracy of 11/14, or 79% and the test set data of 12/14 or 86%.
Given the large sample size of 2084 1148 =3232 nuclei, the full data sets were submitted to the discriminant algorithm, considering that the large number of nuclei, of more than 1000 even for the smaller data set, would keep the resubstitution error at a very low percentage [15] .
Feature selection identified most of the features previously selected for the training set, with small differences in mean values, for the full data set. Table 1 lists the mean values and standardized coefficients for features previously selected for the training set. The average accuracy was 66.12%. Using the 50% threshold criterion, the correct classification was 76%. With the 40% criterion, 89% of lesions were correctly classified.
The classification matrix for nuclei, with only its marginal discrimination, suggests that the nuclear populations in cases of nonmetastatic and of metastatic lesions are very similar. One compatible interpretation is that the similarity is due to the presence in both data sets of the same two nuclear phenotypes, and that the only difference between the two diagnostic categories would be due to a difference in proportions of these nuclei, as had been found in cases of cSCC where an aggressive phenotype predominates in cases with poor prognosis [2] .
To test this hypothesis, the discriminant function derived above was applied to every individual case to determine the percentage of nuclei as having an aggressive/metastatic phenotype. Table 3 lists the percentages of nuclei assigned to the metastatic diagnostic category for both the nonmetastatic and the metastatic data sets. A graphic for the distribution of cases with a certain percentage of nuclei assigned to the metastatic category is shown in Fig. 3 . Even though the sample size is small, the Mmeta (metastatic) lesions appear to have a predominance of aggressive nuclei. 
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Discriminant function scores of nuclei from both metastatic and nonmetastatic melanoma lesions. 
Discussion
Only a small percentage of patients with thin melanomas may develop metastasis. It is important to target those high risk patients so that more aggressive treatments and follow-up are offered. In addition, excessive initial therapy may result in needless complications. Wide local excision and lymph node dissection are associated with complication rates of up to 25% [16] [17] [18] . Even sentinel lymph node biopsy is associated with a short-term complication rate of at least 5% [19] . Clearly, the decision to proceed with intensive therapy in patients with thin melanoma is not trivial, and how best to identify patients most likely to benefit from intensive therapy remains a clinical dilemma.
The results of the current exploratory study support the hypothesis that thin melanoma lesions contain two phenotypes of nuclei, and that one of these phenotypes predominates in proportion in lesions that eventually result in progression to metastasis. These results may thus serve as a basis for a larger study on more generally representative clinical material, aimed at the development of an unequivocal prognostic indicator for thin melanoma lesions. Such a prognostic clue would be distinctly different from clues as offered by ploidy analysis or by a multivariate analysis of a number of histopathological characteristics.
In this study that applied the standard criteria for aggressive thin melanomas -such as ulceration and high mitotic index -only one of the 10 patients in the Mmeta group would have been considered for intensive therapy.
In contrast, only five karyometric features descriptive of the nuclear chromatin distribution provided a recognition of more than 70% of patients who might benefit from intensive therapy. The karyometric features relate to subtle changes in the spatial and statistical distribution of the nuclear chromatin, suggesting not only histone modification but also cellular aggression [20] .
Chromatin distribution pattern and structure vary widely in patients with melanomas, and multiple subpopulations of malignant phenotypes might exist [21] . Our results are compatible with those observations, and may allow a new avenue to investigate epigenetic changes in patients with thin melanomas [20, 22] . The concept that subpopulations of cells dominate a tumor's biology is well described in the literature for multiple cancers, including melanomas [23] [24] [25] .
An important limitation of this study is that the majority of patients were male. It has been suggested that some of the risk factors for melanoma such as outdoor activity and sun exposure are more common in males than females, but this is far outside of the scope of this project. There is nothing inherently sex biased in the analysis of chromatin patterns, but the relatively small patient population could make an even small bias more pronounced. The robustness of that suggests that these results are useful in patients of both sexes.
The results obtained in this study support the hypothesis of the risk for progression to metastatic disease associated with a high proportion of nuclei of a progressive phenotype. The study had a follow-up period of nearly 5 years, yet, there clearly are limitations to the generalization of the collected results. The patient numbers were small, and there is the problem of selection bias. Most of the patients underwent sentinel node biopsy at the time of the initial procedure. Thus, patient and tumor characteristics may have alerted the surgeon to the risk of an aggressive phenotype. We do not know how surgeons decided how to proceed with sentinel node biopsy. With the small number of patients, the role of high mitotic index and ulceration could not be adequately investigated. A definitive demonstration of the utility of a karyometric prognostic criterion for thin melanomas should involve stratification for ulceration, mitotic index and tumor stage. The multiplicity and varied nature of histopathological clues investigated for prognostic efficacy, and the limited clinical utility, reflect the substantial diversity and differences in presentation of malignant melanomas. Overall, the observed lesion diversity leaves the identification of unequivocal prognostic criteria for thin melanoma lesions to future research. However, we have demonstrated in this training set that karyometry appears to identify lesions with high proportions of nuclei that may lead to the early identification of metastatic melanoma. In conclusion, karyometry may have a role in decision-making for patients with thin melanoma. Further study is warranted to examine its utility in this setting.
